Harmony Biosciences to present EPX-100 epilepsy data at European Epilepsy Congress
AI Summary- Harmony Biosciences will present EPX-100 data at the 16th European Epilepsy Congress.
- September 6 features two posters covering ARGUS extension results and selected CYP-enzyme interactions.
- ARGUS and LIGHTHOUSE trials are enrolling patients with Dravet syndrome and Lennox-Gastaut syndrome, respectively.